No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

RAND Corporation 2020 Report Finds: Silver-nylon Dressing May be a Useful Strategy in Preventing Infections While Providing Prolonged Care of Burn Injuries

Editor: What To Know

  • A Review of Scientific Literature” includes key findings and recommendations for silver-plated nylon dressing technology and its effectiveness in infection prevention and prolonged care of military burn injuries — a leading cause of fatality of service members.
  • “We are honored to have the credibility of the RAND Corporation's rigorous, evidence-based analysis of the research that affirms the effectiveness of our silver-plated nylon dressings in treating burn and blast injuries,” said Raul Brizuela, president and CEO of Argentum Medical.
  • The RAND Corporation 2020 report includes summary recommendations based on results of the literature review and synthesis of the evidence that point to silver nylon dressing as a potential standard of care.

December 15, 2020

RAND Corporation 2020 Report, “The Effect of Blast-Related Burn Injuries from Prolonged Field Care to Rehabilitation and Resilience: A Review of Scientific Literature includes key findings and recommendations for silver-plated nylon dressing technology and its effectiveness in infection prevention and prolonged care of military burn injuries — a leading cause of fatality of service members.

The RAND Corporation 2020 report highlights evidence about the antimicrobial properties of SILVERLON dressings as critical to infection prevention after burn or blast injuries,” said LTC Julie Rizzo, MD, FACS, burn and trauma surgeon for the U.S. Institute of Surgical Research. “Because evacuation is not always immediately possible, SILVERLON is ideal for managing burn injuries in prolonged field care settings.”

RAND researchers conducted an independent, comprehensive literature review and synthesis of the evidence surrounding blast-related burn injuries. Findings and recommendations presented in the report are intended to raise awareness about the current state of the science in treating burn injuries.  According to the report, burns are one of the most difficult types of injury to treat:

  • Infection control and prevention are critical to burn care, especially because research shows that pathogens to which service members are exposed in current combat operations are increasingly resistant to antibiotics.
  • Research shows that appropriate bandaging to avoid infection is critical; silver-nylon dressing has been found to be uniquely portable and easy to use and has key antimicrobial properties.
  • The report also includes a 2018 study that found “compared with topical antimicrobial agents, silver-nylon dressing had lower infection rates …”
  • Newer silver-impregnated dressings are ideal for prolonged field care. They can be left in place for seven days without being changed and can be rewetted to be used again.

The RAND Corporation 2020 report includes summary recommendations based on results of the literature review and synthesis of the evidence that point to silver nylon dressing as a potential standard of care:

  • Finally, studies yielding direct applications — such as investigations finding that silver-nylon dressing is uniquely portable and easy-to-use and has key antimicrobial properties — might serve as guideposts for standard setting.

The RAND Corporation 2020 report was sponsored by the U.S. Army Medical Research and Development Command and the DoD Blast Injury Research Coordinating Office, and was conducted within the Forces and Resources Policy Center of the RAND National Security Research Division.

This report from the RAND Corporation — a nonprofit, nonpartisan research organization — is part of the RAND research series that present research findings and objective analysis that address the challenges facing the public and private sectors. The RAND Corporation develops solutions to help make communities throughout the world safer and more secure, healthier and more prosperous.  All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.

We are honored to have the credibility of the RAND Corporation’s rigorous, evidence-based analysis of the research that affirms the effectiveness of our silver-plated nylon dressings in treating burn and blast injuries,” said Raul Brizuela, president and CEO of Argentum Medical. “Originally developed for military combat injuries, our SILVERLON® antimicrobial technology is now used throughout the U.S. Military — and in healthcare settings around the world. Our SILVERLON® dressings contain 50 to 100 times more metallic silver ions than other silver-impregnated dressings.”

SILVERLON’S MILITARY HERITAGE

SILVERLON® was originally developed for the austere and hostile environment of the battlefield and has since maintained its long history with the U.S. Military:

  • The U.S. Army uses SILVERLON® wound-care technology extensively in the management of burn and blast injuries.
  • SILVERLON® is incorporated into numerous deployed Medical Tactical Combat Casualty Care kits and is also supplied in bulk to Combat and Support Hospitals and Tactical Forward Surgical Teams. It is also included in burn care protocols in the Joint Theater Trauma System Clinical Practice Guideline.
  • SILVERLON® burn products and protocols are extensively used by the U.S. Army and by U.S. Air Force Critical Care Air Transport (CCAT) teams and are included in the U.S. Air Force School of Aerospace Medicine Critical Care Air Transport Basic Course.

Multiple, peer-reviewed, published clinical studies have shown the significant benefits of SILVERLON® in a wide variety of surgical, wound and burn-care settings. Beyond the military, SILVERLON® dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy